Exploring the effect of dapagliflozin on coronary inflammation in type 2 diabetes patients based on the coronary artery perivascular fat attenuation index. - Liu, Xuehua; Zhang, Tian; Fu, Rong; Liu, Dan; Zhang, Jingyi; Hu, Qing; Song, Guangyao; Ren, Luping (Cardiovascular Diabetology, 2025)